Published on 30 Apr 2024 on Benzinga
The cannabis sector saw a notable upswing on Tuesday on news of the Drug Enforcement Administration's (DEA) historic decision to align its stance with a recommendation from the Department of Health and Human Services and move marijuana from Schedule I to Schedule III under the Controlled Substances Act (CSA).
Earlier this year the Dept. of Health and Human Services (HHS) released 252 pages of documents confirming for the first time it recommended to the DEA to reschedule cannabis from Schedule I to Schedule III under the Controlled Substances Act.